Skip to content
★ Sign in to follow
JR

James Robert Atkinson

Total declarations
16
Company
1
▲ Purchases (1 ops.)
€23k
▼ Sales (0 ops.)
—

Latest filing published 21 Jun 2019 for NN INC, €23k.

Filing timeline

BuySale
James Robert Atkinson

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

  • NN INC 1 purchase · last 21 Jun 2019

Since each purchase

  • Filed 21 Jun 2019 · 2698 days ago · €23k
    -52.6%
    Entry US$9.00 · Close at T+365 US$4.27

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

James Robert Atkinson: trading record in brief

James Robert Atkinson discloses dealings in NN Inc to SEC (Form 4). The record holds 16 filings, for trades running from 16 March 2017 to 19 June 2019.

Purchases make up the whole of the open-market record (1 purchase, €23k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 14 share grants and 1 option exercise. 2019 to date brings 1 purchase and no sales.

Most recently, on 21 June 2019, the filings show an open-market purchase worth €23k in NN Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to James Robert Atkinson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ▲
    EVP, Life SciencesExecutivesNN Inc
    25,950 USD29SEC
    3,000 shares@ US$8.6562.8% of flowCommon StockSEC:0000899243-19-017789:0
    Canonical exit: 17 Sept 2019 (T+90)
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    0SEC
    10,004 shares0Common StockSEC:0000899243-19-008242:0
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    2,768 USD12SEC
    349 shares@ US$7.936.6% of flowCommon StockSEC:0000899243-19-008242:1
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    2,595 USD12SEC
    341 shares@ US$7.616.2% of flowCommon StockSEC:0000899243-19-008242:2
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    1,339 USD11SEC
    176 shares@ US$7.613.2% of flowCommon StockSEC:0000899243-19-008242:3
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    0SEC
    990 shares0Common StockSEC:0000899243-18-011178:0
  • ◇
    EVP, Life SciencesExecutivesNN Inc
    0SEC
    679 shares0Common StockSEC:0000899243-18-011178:1
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    9,338 USD12SEC
    460 shares@ US$20.3013.8% of flowCommon StockSEC:0000899243-18-011178:2
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    2,430 USD11SEC
    98 shares@ US$24.803.5% of flowCommon StockSEC:0000899243-18-008291:0
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    7,294 USD12SEC
    290 shares@ US$25.1510.6% of flowCommon StockSEC:0000899243-18-008180:0
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    3,773 USD12SEC
    150 shares@ US$25.155.5% of flowCommon StockSEC:0000899243-18-008180:1
  • ◆
    EVP, Life SciencesExecutivesNN Inc
    0SEC
    3,000 shares0Common StockSEC:0000899243-18-007789:0
  • ◆
    See RemarksExecutivesNN Inc
    1,546 USD2SEC
    56 shares@ US$27.602.5% of flowCommon StockSEC:0000899243-17-011413:0
  • ◆
    See RemarksExecutivesNN Inc
    5,525 USD3SEC
    245 shares@ US$22.559.2% of flowCommon StockSEC:0000899243-17-008259:0
  • ◆
    See RemarksExecutivesNN Inc
    2,009 USD2SEC
    83 shares@ US$24.203.3% of flowCommon StockSEC:0000899243-17-008259:1
  • ◆
    See RemarksExecutivesNN Inc
    0SEC
    1,515 shares0Common StockSEC:0000899243-17-008259:2

16 of 16 declarations